What are the steps to establish a comprehensive quality‑control program covering pre‑analytical, analytical, and post‑analytical phases for haematology testing?

Quality Control in Haematology Laboratory

A comprehensive quality control program in haematology must systematically address pre-analytical, analytical, and post-analytical phases through standardized protocols, continuous monitoring with key performance indicators, mandatory proficiency testing, and documented quality assurance activities.

Framework for Quality Control Program

The establishment of quality control in haematology requires monitoring and evaluating laboratory policies across all three testing phases, as the pre-analytical phase accounts for over 60% of all laboratory errors, followed by post-analytical errors at over 20% 1. This three-phase approach is essential for minimizing patient risk and driving quality improvement 2.

Pre-Analytical Phase Controls

Specimen Management

Implement strict protocols for specimen handling from collection through processing:

• Collection procedures: Establish standardized methods for blood collection using appropriate tubes in specified sequence, with proper patient identification 3
• Transport requirements: Define acceptable temperature conditions and time limits for specimen transport to prevent degradation 1
• Processing protocols: Document procedures for specimen identification, processing, and storage with clear time constraints 1
• Information capture: Record comprehensive patient demographics, medical history, concomitant medications, and comorbidities that may affect test results 1

Documentation Requirements

• Maintain detailed records of collection methods, handling procedures, and transport conditions 1
• Retain all primary files, worksheets, and report forms for minimum 2 years or as required by local regulation 1

Analytical Phase Controls

Instrument Performance Monitoring

Focus on continuous surveillance rather than traditional quality control materials:

• Equipment verification: Monitor instrument performance through regular maintenance records and manufacturer-specified protocols 1
• Calibration protocols: Use commercial calibrators for automated instruments in absence of primary reference standards 4
• Key Performance Indicators (KPIs): Implement KPI-based monitoring using routine process data rather than imperfect control materials, as this better reflects actual process quality 1

Quality Control Materials

• Multi-level controls: Use combination of commercial controls (three levels) and retained or fresh patient specimens for monitoring accuracy and precision 4
• Moving averages: Utilize patient red-cell indices moving average data for continuous monitoring of instrument calibration drift 4
• Correlation checks: Verify reliability through correlation of related parameters and careful blood film review 4

Reagent Quality Control

• Establish and document reagent quality control protocols with regular monitoring 1
• Commercial blood culture media and similar prepared materials are exempt from end-user control given supplier batch testing 1

Post-Analytical Phase Controls

Result Reporting Standards

Establish comprehensive reporting protocols with appropriate reference ranges:

• Reference intervals: Determine laboratory-specific reference limits for each test, with separate ranges for adults and children 1
• Result verification: Implement systematic review processes before result release 1
• Discrepancy management: Contact responsible physicians when unexpected results occur to identify adequate explanations 3
• Reporting format: Provide clear test designations with explanatory descriptions and appropriate units 1

Communication Protocols

• Establish procedures for prompt communication of critical values to clinical teams 1
• Document all result reporting activities and communications 1

Personnel Training and Competence

Mandatory Training Components

Implement comprehensive training programs addressing all aspects of testing:

• Initial training: Basic manufacturer training plus hands-on workshops for operators and supervisors 1
• Director education: Specialized education for laboratory directors through workshops and professional programs 1
• Continuing education: Regular updates on new developments through meetings and workshops 1
• Competence assessment: Establish job descriptions, training protocols, confirmation procedures, and routine re-assessment before task performance 1
• Regulatory compliance: Ensure adherence to federal and state training regulations 1

Proficiency Testing and External Quality Assurance

Performance Evaluation Requirements

Laboratories must participate in approved proficiency testing programs:

• Mandatory participation: Successfully complete performance evaluation programs approved by regulatory authorities (e.g., CLIA '88 requirements) 1
• Peer comparison: Use external quality assurance for analytical surveillance and comparison with peer group data 2, 4
• Scope of testing: Participate in programs covering all routinely performed tests and, when available, infrequently performed tests 4

Quality Assurance Documentation and Review

Systematic Monitoring Activities

Document all quality assurance activities with regular review cycles:

• Policy review: Review and revise laboratory policies at established intervals or as necessary 1
• Problem identification: Inform all staff of problems identified during quality assurance reviews 1
• Corrective actions: Document corrective actions taken to prevent recurrences 1
• Internal audits: Perform regular internal audits and management reviews 1
• Non-conformity assessment: Establish procedures for identifying and addressing non-conformities 1

Critical Pitfalls to Avoid

Common errors that compromise quality control:

• Inadequate pre-analytical monitoring: Failing to monitor blood volume per bottle AND number of bottles collected, which prevents detection of improper ordering 1
• Inappropriate quality control materials: Using easy-to-grow strains at unrealistic concentrations that don't reflect routine practice 1
• Insufficient time constraints: Ignoring time limitations for specimen processing, particularly for differential counts requiring completion within 6 hours 1
• Missing correlation checks: Failing to verify results through related parameter correlation and blood film review 4
• Inadequate documentation: Not maintaining comprehensive records of all quality control activities 1